Analysis: Kimia Biosciences Ltd.

BSE:KIMIABL Pharmaceuticals Bulk Drugs Market cap: ₹136 cr
RS rating: 34 Stage: Stage 4

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Kimia Biosciences Ltd. and 4,900+ companies.

Sign in
5-day free pass. No card required.